Studies indicate that a high expression of MOR in malignant specimens were associated with worse survival outcome in patients with lung cancer, hepatocellular carcinoma, and laryngeal squamous cell carcinoma (6–8). The gene discussed is OPRM1; the disease is lung cancer.